This website uses cookies. By using the site you are agreeing to our Privacy Policy.


News from Tokyo Headquarters

Display news for healthcare professionals

The news releases are issued by FUJIFILM Corporation in Japan.
Fujifilm makes no representation that products on these news releases are commercially available in all countries and regions.

Please note that contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.

Apr 11, 2024
Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina
News Release Bio-CDMO CDMO
Feb 29, 2024
FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA with Better Energy for Denmark Manufacturing Site
News Release Bio-CDMO CDMO Sustainability
Dec 4, 2023
Fujifilm to Invest USD 200 Million to Expand Cell Therapy Development and Manufacturing Capabilities
News Release Bio-CDMO CDMO Life Sciences
Nov 7, 2023
FUJIFILM Diosynth Biotechnologies Announces First Tenant for New Manufacturing Facility 
News Release Bio-CDMO CDMO
Jun 5, 2023
Fujifilm to Enhance Commercial Presence in Asia for Biologics and Advanced Therapies Contract Services 
News Release Bio-CDMO CDMO
Mar 31, 2023
Transfer of FUJIFILM Healthcare Systems’ electronic medical record and medical-receipt systems related business to PHC Holdings’ subsidiary
News Release Healthcare IT
Dec 19, 2022
Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business
News Release M&A, Investment Healthcare IT
Dec 13, 2022
Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund
News Release Regenerative Medicine M&A, Investment
Oct 5, 2022
Fujifilm to establish its first Bio-CDMO site in Japan
News Release Bio-CDMO CDMO M&A, Investment
Jun 29, 2022
Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
News Release Bio-CDMO CDMO M&A, Investment
Apr 4, 2022
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
News Release M&A, Investment Bio-CDMO CDMO
Mar 22, 2022
Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business
Amendment in relation to a return of domestic marketing rights for a product
News Release Pharmaceuticals
Sep 2, 2021
Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business to PeptiDream
News Release Pharmaceuticals
Aug 31, 2021
Launch of Therapeutic Radiopharmaceutical Product, Lutathera® Injection targeting neuroendocrine tumors in Japan (FUJIFILM Toyama Chemical)
News Release Pharmaceuticals